ARKGvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with ARKG, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG ETF 2 | -3.25%– | +36.71%– | +76.72%– | +65.56%– | +132.21%– | -29.90%– |
| Flows | ARKG ETF 2 | +$37M– | +$51M– | +$90M– | +$63M– | -$431M– | -$2.01B– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG ETF 2 | +49.99%– | +44.59%– | +44.73%– | +46.89%– |
| Max drawdown | ARKG ETF 2 | -17.81%– | -27.52%– | -46.41%– | -76.56%– |
| Max drawdown duration | ARKG ETF 2 | 22d– | 126d– | 882d– | 1818d– |
Trading data
ARKG | ETF 2 | |
Last sale 10/28/2026 at 1:30 PM | $54.82 | – |
| Previous close 10/27/2026 | $51.65 | – |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
ARKG | ETF 2 | |
|---|---|---|
| Last price | $54.82 | – |
| 1D performance | +6.14% | – |
| AuM | $2.18 B | – |
| E/R | 0.75% | – |
Characteristics
ARKG | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Ark Investment | – |
| Benchmark | - | – |
| N° of holdings | 31 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
ARKG
USA
88.62%
Other
11.38%
ETF 2
Sectors
ARKG
Healthcare
97.89%
Other
2.11%
ETF 2
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.64%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about ARKG
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
